1997 ◽
Vol 62
(1)
◽
pp. 100-100
◽
R P Kinkel
◽
R A Rudick
◽
R M Ransohoff
1996 ◽
Vol 155
(2)
◽
pp. 455-458
◽
Gerd Lummen
◽
Mark Goepel
◽
Stefan Mollhoff
◽
Axel Hinke
◽
Thomas Otto
◽
...
Gerd Lummen
◽
Mark Goepel
◽
Stefan Mollhoff
◽
Axel Hinke
◽
Thomas Otto
◽
...
2003 ◽
Vol 2
(1)
◽
pp. 182
K. Rohrmann
◽
R. Oberneder
◽
H. Pohla
◽
A. Hofstetter
◽
M. Siebels
2004 ◽
Vol 3
(2)
◽
pp. 111
M. Siebels
◽
K. Rohrmann
◽
H. Pohla
◽
A. Hofstetter
2006 ◽
Vol 5
(2)
◽
pp. 257
A. Bex
◽
M. Kerst
◽
H. Mallo
◽
W. Meinhardt
◽
S. Horenblas
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 16088-16088
◽
L. V. Demidov
◽
I. V. Tsimafeyeu
◽
U. A. Naidzionak
1995 ◽
Vol 72
(6)
◽
pp. 1531-1535
◽
G Facendola
◽
MC Locatelli
◽
G Pizzocaro
◽
L Piva
◽
C Pegoraro
◽
...
2005 ◽
Vol 3
(2)
◽
pp. 226-227
◽
1991 ◽
Vol &NA;
(777)
◽
pp. 16
2006 ◽
Vol 49
(1)
◽
pp. 76-81
◽
Axel Bex
◽
Martÿn Kerst
◽
Henk Mallo
◽
Wim Meinhardt
◽
Simon Horenblas
◽
...
Close
Export Citation Format
Close
Share Document
Close
Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.
